Search

Manufacture Facilities

Taking Sustainability to Heart: An Interview With ten23 Health

09/29/2023 | Stephanie Vine | 11 min read

We sit down with Hanns-Christian Mahler, CEO of ten23 health.

Manufacture Bioprocessing - Upstream & Downstream

Less Patience, More Patients

09/28/2023 | 4 min read

Sitting Down With Dick Sundh, General Manager, Kite Pharma

Discovery & Development Drug Discovery

The FLEET of Hope

09/27/2023 | Robert H Cichewicz | 3 min read

Fungal infections and antifungal resistance are a significant problem; here’s one approach to consider

Manufacture Facilities

Center of Excellence Opens for RNA

09/26/2023 | Stephanie Vine | 4 min read

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

Manufacture Technology and Equipment

Tooling Up for Biopharma’s Digital Future

09/25/2023 | Sponsored by Sartorius | 7 min read

How digitalization will revolutionize the way we develop and optimize bioprocesses.

Manufacture Bioprocessing - Upstream & Downstream

Getting More from Your Buffer Management Strategy

09/25/2023 | Sponsored by Asahi Kasei Bioprocess | 7 min read

We delve into the story behind Lonza’s collaboration with Asahi Kasei Bioprocess America.

Manufacture Advanced Medicine

Cell yourself

09/25/2023 | Molly Mjolsness | 5 min read

Navigating the cell therapy partnership selection process can be complex. Here, I share the questions you should be asking to help you get it right.

Manufacture Bioprocessing - Upstream & Downstream

Planes, Trains, and Autologous Therapies

09/22/2023 | Sumukhi Sreevatsan | 3 min read

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

Discovery & Development Drug Discovery

Meet an AI Model that Predicts Teratogenicity

09/21/2023 | Jamie Irvine | 3 min read

Researchers demonstrate that complex data analysis paired with artificial intelligence can predict additional causes of Teratogenicity

Discovery & Development Drug Discovery

CRISPR With Caution

09/19/2023 | Rob Coker | 3 min read

Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing